[HTML] jci.org

[HTML][HTML] Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

SJF Chong, F Zhu, O Dashevsky… - The Journal of …, 2023 - Am Soc Clin Investig
The B cell leukemia/lymphoma 2 (BCL-2) inhibitor venetoclax is effective in chronic
lymphocytic leukemia (CLL); however, resistance may develop over time. Other lymphoid …
被引用次数：11 相关文章

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

SJF Chong, F Zhu, O Dashevsky… - The Journal of …, 2023 - mdanderson.elsevierpure.com
The B cell leukemia/lymphoma 2 (BCL-2) inhibitor venetoclax is effective in chronic
lymphocytic leukemia (CLL); however, resistance may develop over time. Other lymphoid …

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

SJF Chong, F Zhu, O Dashevsky… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
The B cell leukemia/lymphoma 2 (BCL-2) inhibitor venetoclax is effective in chronic
lymphocytic leukemia (CLL); however, resistance may develop over time. Other lymphoid …
[HTML] nih.gov

[HTML][HTML] Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

SJF Chong, F Zhu, O Dashevsky, R Mizuno… - The Journal of …, 2023 - ncbi.nlm.nih.gov
The B cell leukemia/lymphoma 2 (BCL-2) inhibitor venetoclax is effective in chronic
lymphocytic leukemia (CLL); however, resistance may develop over time. Other lymphoid …

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies.

SJF Chong, F Zhu, O Dashevsky, R Mizuno… - The Journal of …, 2023 - europepmc.org
The B cell leukemia/lymphoma 2 (BCL-2) inhibitor venetoclax is effective in chronic
lymphocytic leukemia (CLL); however, resistance may develop over time. Other lymphoid …

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

SJF Chong, F Zhu, O Dashevsky… - Journal of Clinical …, 2023 - search.proquest.com
The B cell leukemia/lymphoma 2 (BCL-2) inhibitor venetoclax is effective in chronic
lymphocytic leukemia (CLL); however, resistance may develop overtime. Other lymphoid …

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies.

S Chong, F Zhu, O Dashevsky, R Mizuno… - Journal of Clinical …, 2023 - escholarship.org
The B cell leukemia/lymphoma 2 (BCL-2) inhibitor venetoclax is effective in chronic
lymphocytic leukemia (CLL); however, resistance may develop over time. Other lymphoid …

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies.

SJF Chong, F Zhu, O Dashevsky, R Mizuno… - The Journal of …, 2023 - europepmc.org
The BCL-2 inhibitor venetoclax is effective in chronic lymphocytic leukemia (CLL); however,
resistance may develop over time. Other lymphoid malignancies such as diffuse large B-cell …